@article{8fa6ff502f9a44cf9fb6ec2cc433a07d,
title = "Optic neuropathy in patients with glioblastoma receiving bevacizumab",
author = "Sherman, \{J. H.\} and Aregawi, \{D. G.\} and A. Lai and Fathallah-Shaykh, \{H. M.\} and Bierman, \{P. J.\} and K. Linsky and Larner, \{J. M.\} and Newman, \{S. A.\} and D. Schiff",
note = "Funding Information: Disclosure: Dr. Sherman and Dr. Aregawi report no disclosures. Dr. Lai has served on scientific advisory boards for Genentech, Inc. and Schering-Plough Corp.; serves on the editorial board of the Journal of Neuro-Oncology; and receives research support from Genentech, Inc., Schering-Plough Corp., the NIH/NCI [1KO8CA124479-01A1 (PI)], and the American Brain Tumor Association. Dr. Fathallah-Shaykh has served on a scientific advisory board for Genentech, Inc. and serves on the editorial board of the Archives of Neurology. Dr. Bierman reports no disclosures. Dr. Linsky receives research support from the Doris Duke Charitable Foundation (Clinical Research Fellowship for Medical Students). Dr. Larner has served on review panels for the US Department of Defense and receives research support from the NIH [5R01 ES011975-05 (PI), [5 R01 CA120413-02 (PI)]. Dr. Newman serves on editorial boards of the Journal of Neuro-Ophthalmology, Skull Base Surgery, EYENET, Ophthalmology, and Evidence-Based Eye Care; and has received honoraria for lectures and/or educational activities not funded by industry. Dr. Schiff has served on a scientific advisory board for Genentech, Inc. ",
year = "2009",
month = dec,
doi = "10.1212/WNL.0b013e3181c3fd00",
language = "English (US)",
volume = "73",
pages = "1924--1926",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "22",
}